Radioprotectin-1

Modify Date: 2024-01-15 11:31:42

Radioprotectin-1 Structure
Radioprotectin-1 structure
Common Name Radioprotectin-1
CAS Number 1622006-09-0 Molecular Weight 486.92
Density N/A Boiling Point N/A
Molecular Formula C23H19ClN2O6S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Radioprotectin-1


Radioprotectin-1 is a potent and specific nonpaid agonist of LPA2, with an EC50 value of 25nM for murine LPA2 subtype[1].

 Names

Name Radioprotectin-1

 Radioprotectin-1 Biological Activity

Description Radioprotectin-1 is a potent and specific nonpaid agonist of LPA2, with an EC50 value of 25nM for murine LPA2 subtype[1].
Related Catalog
Target

EC50: 25 nM (murine LPA2 subtype)[1]

In Vitro Radioprotectin-1 is a potent agonist of LPA2 with an EC50 of 5 pM and functions as a full agonist at the human ortholog of LPA2[1]. Radioprotectin-1 (0-3 μM; 15 minutes) effectively reduces apoptosis induced by γ-irradiation and the radiomimetic drug Adriamycin in cells that expressed LPA2 either endogenously or after transfection[1]. Cell Viability Assay[1] Cell Line: MEF cells , IEC-6 cells Concentration: 0 μM, 0.1 μM, 0.3 μM, 1.0 μM,3 μM Incubation Time: 15 minutes Result: Protected cells from apoptosis by γ-irradiation- and the radiomimetic chemotherapeuticAdiamycin.
In Vivo Radioprotectin-1 is a high-potency specific agonist of the murine LPA2 GPCR [1]. Radioprotectin-1 (0.1 mg/kg, 0.3 mg/kg; s.c.; every 12 hours; for 3 days) decreases the mortality of C57BL/6 mice in models of the hematopoietic acute radiation syndromes (HE-ARS) and gastrointestinal acute radiation syndromes (GI-ARS) [1]. Radioprotectin-1 exerts its radioprotective and radiomitigative action through specific activation of the upregulated LPA2 GPCR in Lgr5+stem cells[1]. Animal Model: 8-10 weeks old C57BL/6 female mice bearing total body irradiation (TBI) [1] Dosage: 0.1 mg/kg, 0.3 mg/kg Administration: Subcutaneous injection; every 12 hours; for 3 days Result: Decreased mortality of C57BL/6 mice in models of the HE-ARS and the GI-ARS.
References

[1]. Kuo B, et al. The LPA2 receptor agonist Radioprotectin-1 spares Lgr5-positive intestinal stem cells from radiation injury in murine enteroids. Cell Signal. 2018 Nov;51:23-33.

 Chemical & Physical Properties

Molecular Formula C23H19ClN2O6S
Molecular Weight 486.92
Storage condition 2-8℃
Top Suppliers:I want be here

Get all suppliers and price by the below link:

Radioprotectin-1 suppliers

Radioprotectin-1 price

Related Compounds: More...
Propane,1,1-bis(ethylsulfonyl)-2-methyl-
6330-46-7
Pyridinium, 1- (2-hydroxy[1,1:3,1-terphenyl]-5-yl)-2,4, 6-triphenyl-, perchlorate (salt)
14514-74-0
Cyclohexanecarboxylicacid, 1-methyl-3-oxo-, ethyl ester
7356-04-9
2-[1-(2-hydroxy-3,5-dimethylphenyl)cyclohexyl]-4,6-dimethylphenol
144146-25-8
3-[1-(2,5-dimethylthiophen-3-yl)octadecyl]-4-propan-2-ylideneoxolane-2,5-dione
144137-47-3
trans-1,2-Dimethylcyclohexane
6876-23-9
Isobenzofuran,1,3,3a,4,7,7a-hexahydro-, trans- (9CI)
3470-42-6
Pyrido[1,2-a][1,4]diazepine,decahydro-2-methyl-4-nitro-4-pentyl-, hydrochloride (1:2)
62175-99-9
4H-1,3,6,2-Dioxazastannocine,tetrahydro-2,2-bis(2-methylpropyl)-
61947-28-2
5-acetyl-6-methyl-3-nitro-1H-pyridin-2-one
142327-86-4
Ethyl 1-ethyl-1,4-dihydro-4-oxo-5-phenyl-3-pyridinecarboxylate
74632-05-6
6-Methoxy-3-((4-methoxyphenyl)sulfonyl)-4-(3-methylpiperidin-1-yl)quinoline
866895-25-2
3-((4-Chlorophenyl)sulfonyl)-4-(4-(4-methoxyphenyl)piperazin-1-yl)quinoline
866895-40-1
4-(2-chlorobenzyl)-1-(2,4,5-trimethoxyphenyl)[1,2,4]triazolo[4,3-a]quinazolin-5(4H)-one
866896-48-2
4-(3-nitrobenzyl)-2-phenyl-2H-1,2,4-benzothiadiazin-3(4H)-one 1,1-dioxide
866896-68-6
N-(3-chlorophenyl)-3-[(4-methoxyphenyl)sulfonyl][1,2,3]triazolo[1,5-a]quinazolin-5-amine
866896-83-5
N-(3-methoxypropyl)-4-oxo-8-phenyl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazine-3-carboxamide
946335-04-2
N-[2-(2-hydroxyethoxy)ethyl]-4-oxo-8-phenyl-4H,6H,7H,8H-imidazo[2,1-c][1,2,4]triazine-3-carboxamide
941889-85-6
2-((3-(4-fluorophenyl)-4-oxo-3,4-dihydrobenzofuro[3,2-d]pyrimidin-2-yl)thio)-N-(p-tolyl)acetamide
866896-85-7